Back to Top Skip to main content

Global Health Engagement

The Department of Defense executes Global Health Engagement or "GHE" activities to establish and improve the capabilities of Partner Nations' military or civilian health sectors, or those of the DoD. 

Global Health Engagement Spotlight

DoD's GHE activities advance operational readiness and protect our troops, build interoperability so we can work more effectively with the armed forces of our partner nations, and enhance security cooperation so DoD can establish and maintain strong relationships around the world.  A key enabler to regional stability and security for DoD's combatant commands, GHE reduces risks to U.S. armed forces while fostering mission capability of partner nations' forces so that together, we can continue working effectively to defend global interests. 

Read more about the DoD's policy for Global Health Engagement

You also may be interested in...

DHA IPM 18-020: Guidance for the Provision of Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) for Persons at High Risk of Acquiring HIV Infection

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (f): • Establishes the Military Health System’s (MHS) guidance for the provision of HIV PrEP for persons at high risk of HIV acquisition (ACQ). • Describes the elements and resources required to implement an HIV PrEP program. • Establishes the indications for HIV PrEP, laboratory (lab) testing and monitoring, and prescribing of HIV PrEP. • Provides a link to an HIV PrEP toolkit for providers. • This DHA-IPM is effective immediately; it will be converted to a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

2016-2017 Department of Defense Influenza Surveillance Program Sentinel Sites

Policy

The DoD Global, Laboratory-based, Influenza Surveillance Program, at USAFSAM selects military treatment facilities (MTFs) from worldwide locations to participate as Sentinel Sites. Installations are selected annually based on mission, population, deployment/operations tempo and type, and geographic location. Particular focus is on impact to critical operations, highly heterogeneous, mobile populations, potential for new strain production, and past performance. The 2016-2017 Sentinel Site listing (attached) was approved by the USAFSAM team in April 2016, in committee, and has remained unchanged for 2 years.

DoD Directives 6485.02E: DoD Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) Prevention Program (DHAPP) to Support Foreign Militaries

Policy

This directive reissues DoD Directive (DoDD) 6485.02E (Reference (a)) to establish policy and assign responsibilities for DHAPP to support foreign militaries pursuant to Public Law 110-293 (Reference (b)); designates the Secretary of the Navy as the DoD Executive Agent (EA) for DHAPP in accordance with DoDD 5101.1 (Reference (c)); updates the responsibilities for the Coordinating Board for DHAPP (referred to in this directive as the Coordinating Board (CB)), consistent with DoD Instruction (DoDI) 5105.18 (Reference (d)).

DoD Instruction 6485.01: Human Immunodeficiency Virus (HIV) in Military Service Members

Policy

Updates policy for the identification, surveillance, and management of military personnel infected with the Human Immunodeficiency Virus (HIV) and for prevention activities to control transmission of HIV.

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

MHS Training Directive for Medical Stability Operations

Policy

MHS Training Directive for Medical Stability Operations

Joint Pub 3-07, Stability Operations, September 29, 2011

Policy

DoD Support to Foreign Disaster Relief Handbook

Policy

DoD Support to Foreign Disaster Relief Handbook

HA 97-032: Policy for HIV, Drug, and Alcohol Testing for USUHS Accessions

Policy

This memo establishes policy for HIV, Drug, and Alcohol Testing for USUHS Accessions

HA 96-034: Request for Medical Records or Medical Information Concerning HIV-Positive Members

Policy

This memo discusses protecting the confidentiality of medical records and medical information for HIV positive service members.

Presidential Decision Directive

Policy

This Directive establishes national policy and implementing actions to address the threat of emerging infectious diseases by improving surveillance, prevention, and response measures.

<< < 1 > >> 
Showing results 1 - 13 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing; Download a PDF Reader or learn more about PDFs.